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years were lower for all methods. Inter-reader ICCs over 2 and
6 years, respectively, were 0.19 and 0.57 OARSI, 0.15 and 0.47
for KL, and 0.31 and 0.71 for VV. The percentage of patients
with progression based on the SDC for each reader is shown in
the table. Kappas for agreement on progression between readers
after 2 years ranged from 0.26 to 0.38 for OARSI, 0.08 to 0.38
for KL and 0.12 to 0.50 for VV. After 6 years kappas ranged from
0.40 to 0.56 for OARSI, 0.37 to 0.53 for KL and 0.45 to 0.66 for
VV. Sensitivity to change expressed by the SRM was moderate to
large over both follow-up periods.
Intra-reader ICC, percentage progression and SRMs over 2-yr and 6-yr follow-
up for OARSI, KL and VV
Method Reader 2-yr 6-yr
Progression SRM Progression SRM
OARSI 1 27% 0.56 48% 0.82
2 23% 0.65 57% 1.08
3 10% 0.73 34% 1.17
KL 1 19% 0.58 51% 1.10
2 24% 0.82 57% 1.25
3 12% 0.84 42% 1.33
VV 1 20% 0.45 30% 0.59
2 11% 0.46 23% 0.62
3 17% 0.92 36% 1.12
Conclusions: This multicenter study shows that cross-sectional
reproducibility is high for all methods. However, longitudinal repro-
ducibility is moderate for all three scoring methods, even if trained
readers and methods to enhance consistency are used. Sensitivity
to change was high, indicating that radiological changes can be
detected over a two year period. More research on the clinimetric
properties of radiological scoring methods for hand OA is needed
to determine their value in clinical research.
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Purpose: To assess whether inﬂammation on ultrasound is pre-
dictive of clinical response to intraarticular corticosteroid injections
in patients with knee osteoarthritis (OA).
Methods: Patients with symptomatic knee OA were included in
the study. Patients were randomized to receive either an intraartic-
ular injection of 40mg of triamcinolone acetonide in the treatment
group or 1cc of 0.9% saline in the placebo group. Clinical re-
sponse was assessed by changes in baseline WOMAC scores
and physician global assessment at 4 and 12 weeks. Ultrasounds
were performed at each visit.
Results: 79 patients were enrolled into the study. Four-week data
are available for 67 patients in the primary analysis. There was
no change in the WOMAC pain subscale score from baseline to
4 weeks in the control group. There was a signiﬁcant improve-
ment in WOMAC pain subscale score from 10.8 (SD ± 3.2) at
baseline to 8.75 (SD ± 4.0) at 4 weeks in the treatment group
(p<0.001). Of the 34 patients in the treatment group, 16 patients
(47%) had inﬂammatory disease and 18 patients (53%) had non-
inﬂammatory disease as determined by ultrasound. There was no
difference in the change in WOMAC pain subscale score between
the inﬂammatory and noninﬂammatory patients in the treatment
group at 4 weeks. However, there was a statistically signiﬁcant
greater improvement in WOMAC pain subscale score among non-
inﬂammatory patients than among inﬂammatory patients at 12
weeks.
Conclusions: Intraarticular corticosteroid injections are an effec-
tive treatment for symptomatic knee OA compared to placebo.
Patients with noninﬂammatory characteristics on ultrasound ap-
peared to have more prolonged beneﬁt from IA corticosteroids
compared to inﬂammatory patients. This could be due to more
aggressive baseline inﬂammatory disease activity superseding the
beneﬁt of corticosteroids over time. Further studies should be
done to characterize the role of inﬂammation as a potential target
for treatment in OA.
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Purpose: The presence of bone marrow lesions (BMLs) have
been linked to pain and progression of disease in knee os-
teoarthritis (OA). This study aims to determine the relationship
between bone marrow lesions (BMLs) and cartilage volume at
baseline, cartilage volume loss over 2 years, and risk of knee joint
replacement over 4 years, in subjects with knee OA.
Methods: One hundred and nine men and women with mild to
moderate symptomatic knee OA were recruited to have MRIs
performed at baseline and 2 years later to assess knee structure,
including tibial cartilage volume and BMLs. They were contacted
at 4 years to determine whether they had a knee replacement.
Results: BMLs were present in 66% of the subjects at baseline.
BMLs was negatively associated with total tibial cartilage volume
at baseline (B -129.19 ml; 95%CI -215.28, -43.09), as well as
medial and lateral tibial cartilage volumes (p<0.001 and p=0.004
respectively). One hundred participants had a second MRI, ap-
proximately 2 years later. There were no signiﬁcant differences
between those who had a BML at follow up and those who did
not. Subjects with a higher BML score at baseline had increased
total tibial cartilage volume loss (p=0.01) and are at greater risk
of having a knee joint replacement over 4 years (OR 1.44; 95%CI
1.03, 2.02) than those without BMLs present.
Conclusions: In participants with symptomatic knee OA, the
prevalence and severity of BMLs are associated with less total
tibial cartilage and greater cartilage loss over 2 years. People with
symptomatic knee OA with BML are more susceptible to requiring
a knee joint replacement over 4 years. Our study suggests that it
may be possible to use BMLs to detect those who are at higher
risk of disease progression, which may enable early detection and
better management of the disease to prevent progression and the
subsequent need for surgery.
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Purpose: Arthritis is a leading cause of disability in the United
States. Total knee arthroplasty (TKA) has become the gold stan-
